Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16518666 | 1.00 | DPP4 (0.35) | DPP4CYP3A4 | |
| SCHEMBL10202323 | 1.00 | DPP4 (0.35) | DPP4CYP3A4 | |
| SCHEMBL10203871 | 0.82 | ALDH1A1 (0.37) | DPP4 | |
| SCHEMBL10202114 | 0.81 | DPP4 (0.36) | DPP4 | |
| SCHEMBL24015813 | 0.79 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL10202111 | 0.79 | POLB (0.38) | DPP4 | |
| SCHEMBL10202326 | 0.79 | USP2 (0.38) | DPP4CYP3A4 | |
| SCHEMBL10203108 | 0.79 | POLB (0.38) | DPP4 | |
| SCHEMBL4204214 | 0.78 | DPP4 (0.31) | DPP4 | |
| SCHEMBL19353533 | 0.78 | TET3 (0.32) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2635571-B1 | NOVEL INHIBITORS OF HEPATITIS C VIRUS | THERAVANCE BIOPHARMA R & D IP LLC (US) | 2015-08-12 | — | — | EP | disclosed |